the efficacy of preventive treatment with ambroxol has been evaluated in pregnant women at 35 weeks or less gestation presentig with a real risk of neonatal respiratory distress syndrome.
PREVENTION OF THE RESPIRATORY DISTRESS SYNDROME WITH AMBROXOL: Report of our experience
LITTA, PIETRO SALVATORE;
1990
Abstract
the efficacy of preventive treatment with ambroxol has been evaluated in pregnant women at 35 weeks or less gestation presentig with a real risk of neonatal respiratory distress syndrome.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.